|
US6890951B2
(en)
|
1998-08-05 |
2005-05-10 |
Brookhaven Science Associates Llc |
Treatment of addiction and addiction-related behavior
|
|
CZ20013061A3
(cs)
*
|
1999-02-24 |
2002-06-12 |
University Of Cincinnati |
Pouľití sulfamátových derivátů pro léčbu poruch kontroly impulsů
|
|
NZ514812A
(en)
*
|
1999-04-08 |
2005-01-28 |
Ortho Mcneil Pharm Inc |
Anticonvulsant derivatives useful in lowering blood pressure
|
|
JP4709392B2
(ja)
*
|
1999-04-08 |
2011-06-22 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
血液グルコースレベルを下げることに有用な抗痙攣薬誘導体
|
|
JP2002541199A
(ja)
*
|
1999-04-08 |
2002-12-03 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
脂質を下げることに有用な抗痙攣薬誘導体
|
|
WO2000061140A1
(en)
*
|
1999-04-08 |
2000-10-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in maintaining weight loss
|
|
NZ514811A
(en)
*
|
1999-04-08 |
2005-01-28 |
Ortho Mcneil Pharm Inc |
Anticonvulsant derivatives useful in reducing blood glucose levels
|
|
US7674776B2
(en)
*
|
1999-06-14 |
2010-03-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US20080103179A1
(en)
*
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
US7659256B2
(en)
*
|
1999-06-14 |
2010-02-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US20080255093A1
(en)
*
|
1999-06-14 |
2008-10-16 |
Tam Peter Y |
Compositions and methods for treating obesity and related disorders
|
|
US7056890B2
(en)
*
|
1999-06-14 |
2006-06-06 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US7553818B2
(en)
*
|
1999-06-14 |
2009-06-30 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
EP1309324B1
(en)
*
|
2000-07-07 |
2006-03-22 |
Ortho-McNeil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
|
|
US6946243B2
(en)
|
2000-07-20 |
2005-09-20 |
Solvay Pharmaceuticals Gmbh |
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
|
|
DE10035227A1
(de)
*
|
2000-07-20 |
2002-01-31 |
Solvay Pharm Gmbh |
Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
|
|
JP2004518718A
(ja)
*
|
2000-10-30 |
2004-06-24 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
抗糖尿病薬および抗痙攣薬を含んで成る併用療法
|
|
US20020082222A1
(en)
*
|
2000-11-30 |
2002-06-27 |
Shapira Nathan Andrew |
Treatments for neurogenetic disorders, impulse control disorder, and wound healing
|
|
US6462084B1
(en)
|
2001-05-14 |
2002-10-08 |
Brookhaven Science Associates, Llc |
Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
|
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
|
US20050025791A1
(en)
*
|
2002-06-21 |
2005-02-03 |
Julius Remenar |
Pharmaceutical compositions with improved dissolution
|
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
|
US6559293B1
(en)
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
|
CA2477923C
(en)
*
|
2002-03-01 |
2021-02-23 |
University Of South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
|
US20040029941A1
(en)
*
|
2002-05-06 |
2004-02-12 |
Jennings Julianne E. |
Zonisamide use in obesity and eating disorders
|
|
KR20110043664A
(ko)
*
|
2002-05-17 |
2011-04-27 |
듀크 유니버시티 |
비만치료방법
|
|
US20050215552A1
(en)
*
|
2002-05-17 |
2005-09-29 |
Gadde Kishore M |
Method for treating obesity
|
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
AU2003297639A1
(en)
*
|
2002-12-02 |
2004-06-23 |
University Of Florida |
Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases
|
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
|
CA2522708C
(en)
*
|
2003-04-29 |
2013-05-28 |
Orexigen Therapeutics, Inc. |
Compositions for affecting weight loss
|
|
US6949518B1
(en)
|
2003-06-25 |
2005-09-27 |
Pao-Hsien Chu |
Methods for treating macular degeneration with topiramate
|
|
US7713959B2
(en)
*
|
2004-01-13 |
2010-05-11 |
Duke University |
Compositions of an anticonvulsant and mirtazapine to prevent weight gain
|
|
JP2007517901A
(ja)
|
2004-01-13 |
2007-07-05 |
デューク・ユニバーシティー |
体重の減少に作用する鎮痙剤及び抗精神病剤の組成物
|
|
US20060160750A1
(en)
*
|
2004-01-13 |
2006-07-20 |
Krishnan K R R |
Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss
|
|
US20060100205A1
(en)
*
|
2004-04-21 |
2006-05-11 |
Eckard Weber |
Compositions for affecting weight loss
|
|
RU2006139930A
(ru)
*
|
2004-05-03 |
2008-06-10 |
Дюк Юниверсити (Сша/Сша) (Us) |
Составы для содействия снижению веса
|
|
TW200612905A
(en)
*
|
2004-06-16 |
2006-05-01 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
MY147767A
(en)
*
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
ES2310366T3
(es)
*
|
2004-08-24 |
2009-01-01 |
Janssen Pharmaceutica Nv |
Nuevos derivados de heteroaril sulfonamida benzo-condensada utiles como agentes anticonvulsivos.
|
|
JP2008545650A
(ja)
|
2005-05-20 |
2008-12-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファミド誘導体の製造方法
|
|
ES2761812T3
(es)
|
2005-11-22 |
2020-05-21 |
Nalpropion Pharmaceuticals Inc |
Composición y métodos de aumento de la sensibilidad a la insulina
|
|
WO2007089318A2
(en)
*
|
2005-11-23 |
2007-08-09 |
Orexigen Therapeutics, Inc. |
Compositions and methods for reducing food cravings
|
|
US20070155827A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
|
|
US8716231B2
(en)
*
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
US8492431B2
(en)
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
US8691867B2
(en)
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
US8497298B2
(en)
*
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US20070155823A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
|
|
US20070191461A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
|
|
US20070191449A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
|
|
US20070191474A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
|
|
US20070191453A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
|
|
US20070191459A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
|
|
WO2007137167A2
(en)
|
2006-05-19 |
2007-11-29 |
Janssen Pharmaceutica N.V. |
Co-therapy for the treatment of epilepsy
|
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
|
AU2007319472B2
(en)
|
2006-11-09 |
2013-01-17 |
Nalpropion Pharmaceuticals Llc |
Methods Of Administering Weight Loss Medications
|
|
KR101971218B1
(ko)
|
2006-11-09 |
2019-08-27 |
오렉시젠 세러퓨틱스 인크. |
신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
|
|
US20090247617A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Abdel-Magid Ahmed F |
Process for the preparation of benzo-fused heteroaryl sulfamates
|
|
US20090247616A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
|
|
WO2009158114A1
(en)
|
2008-05-30 |
2009-12-30 |
Orexigen Therapeutics, Inc. |
Methods for treating visceral fat conditions
|
|
US8580298B2
(en)
*
|
2008-06-09 |
2013-11-12 |
Vivus, Inc. |
Low dose topiramate/phentermine composition and methods of use thereof
|
|
US20090304789A1
(en)
|
2008-06-09 |
2009-12-10 |
Thomas Najarian |
Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
|
|
PE20110060A1
(es)
|
2008-06-23 |
2011-01-31 |
Janssen Pharmaceutica Nv |
Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
|
|
US8815939B2
(en)
*
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
|
EP2523557B1
(en)
|
2010-01-11 |
2019-09-25 |
Nalpropion Pharmaceuticals, Inc. |
Methods of providing weight loss therapy in patients with major depression
|
|
PT2858640T
(pt)
|
2012-06-06 |
2020-06-30 |
Nalpropion Pharmaceuticals Llc |
Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular
|
|
US8652527B1
(en)
|
2013-03-13 |
2014-02-18 |
Upsher-Smith Laboratories, Inc |
Extended-release topiramate capsules
|
|
US9101545B2
(en)
|
2013-03-15 |
2015-08-11 |
Upsher-Smith Laboratories, Inc. |
Extended-release topiramate capsules
|
|
US8969371B1
(en)
|
2013-12-06 |
2015-03-03 |
Orexigen Therapeutics, Inc. |
Compositions and methods for weight loss in at risk patient populations
|
|
US10278948B1
(en)
|
2015-09-03 |
2019-05-07 |
Tian Xia |
Method for transnasal delivery of anticonvulsant and therapeutic treatments
|